Govt Job: For IMTech Doctoral Degree in Pharma Job | Salary Rs. 42,000 pm

Established in 1984, the Institute of Microbial Technology (IMTech) is one of the 37 national laboratories, 6 units, and 39 outreach centers of the Council of Scientific and Industrial Research.

Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

In September, 1989, upon completion of the permanent campus, the Institute shifted to occupy an area of about 47 acres, of which the labs covered 22 acres and the residential campus 25 acres.

Post :Senior Project Associate (01 post)

Project titled : “To Study the mechanism of action of spermidine in pathogenesis of Salmonella enterica, shigella flexneri and staphylococcus aureus.”

Project Code : MLP-0042

Essential Qualification :
(i) Master’s Degree in Natural or Agricultural Sciences/ MVSc or bachelor’s degree in Engineering or Technology or Medicine from a recognized University or equivalent; and

(ii) 4 years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organisations and Scientific activities and services.

OR
Doctoral Degree in Science / Engineering / Technology / Pharma / MD / MS from a recognized University or equivalent

Desirable : The Candidate with an expertise in genetic manipulation, knowledge in animal handling and experience in vivo studies and knowledge in cloning, over-expression and purification of protein is desirable.

Upper Age limit (years) – 40

Monthly Emoluments : Rs.42,000/- + HRA

ROLLING ADVT. NO. 04-02

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert